VitaK

VitaK is a specialized life sciences company and contract research organization focused on the study of Vitamin K and its role in human health. Originally a spin-off from Maastricht University, the company is a global leader in Vitamin K2 research, particularly concerning bone metabolism and cardiovascular health. VitaK provides high-end R&D services, clinical trial management, and proprietary diagnostic assays, such as those measuring desphospho-uncarboxylated Matrix Gla Protein (dp-ucMGP). The company's expertise supports the development of nutraceuticals and functional foods aimed at preventing age-related diseases. Following its acquisition by Kappa Bioscience in 2021, VitaK became part of the Balchem Corporation and continues to operate as a center of excellence for Vitamin K analysis and clinical validation.